Literature DB >> 30641460

Delay in breast cancer diagnosis: a Brazilian cohort study.

G C Medeiros1, L C S Thuler2, A Bergmann3.   

Abstract

OBJECTIVES: To evaluate the delay in breast cancer (BC) diagnosis and its risk factors. STUDY
DESIGN: A cohort study of BC patients referred to treatment at oncological reference hospital, Brazil. Delay in BC diagnosis was defined as a time interval ≥90 days between the first contact with a care provider and a BC diagnosis.
METHODS: The association between independent variables and delay was performed by univariate analysis and multiple logistic regression.
RESULTS: Five hundred and twenty-six women were included in the study. Delay was observed in 68.8% and was associated with performing histopathological examination at oncological reference hospital (odds ratio [OR]: 3.96, 95% confidence interval [CI]: 1.91-8.20) or at another public health service (OR: 2.31; 95% CI: 1.50-3.56) and attending gynecological consultations annually (OR: 3.24; 95% CI: 1.97-5.33) or every 2-3 years (OR: 2.86; 95% CI: 1.55-5.28). Patients who presented a lump as the first sign or symptom had a lower chance of delay (OR: 0.43; 95% CI: 0.29-0.65).
CONCLUSIONS: Improvements in the structure and access to health services are needed to reduce the time to diagnosis.
Copyright © 2018 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast neoplasms; Delayed diagnosis; Epidemiology; Health services accessibility; Healthcare disparities

Mesh:

Year:  2019        PMID: 30641460     DOI: 10.1016/j.puhe.2018.10.012

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  3 in total

1.  Secondary and Quaternary Delays in the Diagnosis of Breast Cancer: Are the Physicians Responsible too?

Authors:  Soumen Das; Radha Raman Mondal; Abhimanyu Basu
Journal:  Indian J Surg Oncol       Date:  2022-03-02

2.  Comparison of the performance of four staging systems in determining the prognosis of breast cancer among women undergoing neoadjuvant chemotherapy.

Authors:  Isabella Cristina Santos Soares; Marcelo Adeodato Bello; Anke Bergmann; Luiz Claudio Santos Thuler
Journal:  Breast Cancer Res Treat       Date:  2021-01-08       Impact factor: 4.872

3.  Shorter delay to treatment by integrated diagnostic services and NGO-provided support among breast cancer patients in two Brazilian referral centres.

Authors:  Lorena Sofia Dos Santos Andrade; Tácila Thamires De Melo Santos; Milena Edite Case de Oliveira; Kedma Anne Lima Gomes; Adriana Raquel Araújo Pereira Soares; Tiago Almeida de Oliveira; Mathias Weller
Journal:  J Public Health Res       Date:  2021-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.